Globus Medical GMED Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 67.9%+7.3pp | 67.4%+8.5pp | 65.3%+7.2pp | 62.8%+3.1pp | 60.6%-1.5pp | |
| Operating margin | 17.2%+7.0pp | 16.3%+9.7pp | 13.4%+8.7pp | 10.7%+7.7pp | 10.2%+5.7pp | |
| Net margin | 18.9%+11.5pp | 18.3%+14.2pp | 15.3%+11.6pp | 13.6%+11.8pp | 7.4%+3.9pp | |
| EBITDA margin | 26.3%+5.6pp | 25.7%+9.1pp | 23.3%+8.3pp | 21%+7.8pp | 20.7%+6.6pp | |
| Free cash flow margin | 19.7%-1.1pp | 20%+3.9pp | 20.9%+9.1pp | 20.1%+12.9pp | 20.8%+12.8pp | |
| Returns | ||||||
| Return on equity | 13.3%+8.7pp | 12.3%+9.8pp | 10%+7.8pp | 8.6%+7.3pp | 4.6%+2.4pp | |
| Return on assets | 11.6%+7.7pp | 10.2%+8.2pp | 8.3%+6.6pp | 7.2%+6.0pp | 3.8%+2.0pp | |
| Return on invested capital | 11.9%— | 11.1%— | 9.6%— | 7.2%— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.1× | 0.6×+0.1× | 0.5×+0.1× | 0.5×-0.1× | 0.5×0.0× | |
| Inventory turnover | 1.4×+0.1× | 1.4×0.0× | 1.3×0.0× | 1.3×-0.4× | 1.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 4.6×+0.1× | 4.3×+1.7× | 4.1×+1.6× | 4.1×+1.7× | 4.4×+2.1× | |
| Quick ratio | 3×+0.2× | 2.7×+1.0× | 2.5×+0.8× | 2.3×+0.8× | 2.7×+1.4× | |
| Cash ratio | 1.2×0.0× | 1.1×+0.1× | 0.8×0.0× | 0.5×0.0× | 1.2×+0.7× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | |
| Net debt / EBITDA | -0.5×+0.2× | -0.5×+1.1× | -0.4×+1.0× | -0.2×+0.8× | -0.7×— | |
| Per Share | ||||||
| Book value per share | $34.24+17.1% | $33.37+10.1% | $32.49+10.2% | $31.47+8.4% | $29.25+0.9% | |
| Valuation | ||||||
| Market capitalization | $11.65B+15.7% | $11.69B+3.8% | $7.73B-20.2% | $7.94B-14.1% | $10.07B+38.7% | |
| Enterprise value | $11.21B+15.6% | $11.28B+6.7% | $7.48B-18.3% | $7.83B-12.4% | $9.7B— | |
| Price / earnings | 19.9×-34.4× | 21.7×-87.6× | 18.3×-87.6× | 22.3×-205× | 54.3×-54.7× | |
| Price / sales | 3.8×-0.3× | 4×-0.5× | 2.8×-1.1× | 3×-1.1× | 4×+0.2× | |
| Price / book | 2.5×0.0× | 2.6×-0.1× | 1.8×-0.6× | 1.8×-0.5× | 2.5×+0.6× | |
| EV / EBITDA | 13.8×-4.9× | 14.9×-10.3× | 11.6×-12.9× | 14.2×-16.0× | 18.7×— | |
| EV / sales | 3.6×-0.2× | 3.8×-0.4× | 2.7×-1.0× | 3×-1.0× | 3.9×— | |
| Free cash flow yield | 5.2%0.0pp | 5%+1.4pp | 7.5%+4.5pp | 6.6%+4.9pp | 5.2%+3.1pp | |
| Earnings yield | 5%+3.2pp | 4.6%+3.7pp | 5.5%+4.5pp | 4.5%+4.1pp | 1.8%+0.9pp | |
| PEG ratio | 0.1×— | 0.1×— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Globus Medical's profit margins?
- Globus Medical (GMED) runs a 67.9% gross margin and a 17.2% operating margin, with a 18.9% net margin.
- Where do Globus Medical's ratios come from?
- Every ratio is computed from Globus Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
